10th Annual Pharmaceutical Regulatory Affairs Summit Asia 2017 – IBC Asia, an Informa business, regulatory affairs pharma.#Regulatory #affairs #pharma


Posted On Jun 12 2018 by

regulatory affairs pharma

Regulatory affairs pharma

With a 9-year track record of successfully bringing to market the latest developments and insights from decision makers, the Pharma Regulatory Affairs Summit remains the only such conference in Asia. Part of the PharmaCon suite of events, the conference affords you the opportunity of getting hot of the press information and networking across various pharma industry segments.

“Met regulatory affairs from various companies across Asia and exchanged information regarding issues we have faced in registering the product.”

Astuti Kurniati, Associate Principal Regulatory Specialist, PT Dexa Medical

Conference Highlights:

  • Regional Government updates on initiatives, reducing backlogs, new guidelines
  • Drug approval bottlenecks – And how to work with regulators to optimise timelines
  • Pharmacovigilance Regulations – REMS vs RMP, PSUR Submissions, and other updates
  • Product Registration, Submission Approval – Masterclass focusing on the region
  • Supply Chain, Labelling and Distribution – Standards and compliance strategies required

Thought Leadership Keynote

Regulatory affairs pharma From Trials to Table – The Move Towards a More Patient-Centric Approach

Ewing Marion Kauffman Foundation and FasterCures, USA

TEDGlobal 2012 Speaker on “Let’s Pool Our Medical Data”

View John’s talk at TEDGlobal 2012 [here]

Regulatory affairs pharma


Last Updated on: June 12th, 2018 at 3:57 am, by


Written by admin


Leave a Reply

Your email address will not be published. Required fields are marked *